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Proper neuronal migration and laminar formation during corticogenesis is essential for
normal brain function. Disruption of these developmental processes is thought to be
involved in the pathogenesis of some neuropsychiatric conditions. Especially, Reelin,
a glycoprotein mainly secreted by the Cajal-Retzius cells and a subpopulation of
GABAergic interneurons, has been shown to play a critical role, both during embryonic
and postnatal periods. Indeed, animal studies have clearly revealed that Reelin is
an essential molecule for proper migration of cortical neurons and finally regulates
the cell positioning in the cortex during embryonic and early postnatal stages; by
contrast, Reelin signaling is closely involved in synaptic function in adulthood. In
humans, genetic studies have shown that the reelin gene (RELN) is associated with a
number of psychiatric diseases, including Schizophrenia (SZ), bipolar disorder (BP) and
autistic spectrum disorder. Indeed, Reln haploinsufficiency has been shown to cause
cognitive impairment in rodents, suggesting the expression level of the Reelin protein
is closely related to the higher brain functions. However, the molecular abnormalities
in the Reelin pathway involved in the pathogenesis of psychiatric disorders are not yet
fully understood. In this article, we review the current progress in the understanding
of the Reelin functions that could be related to the pathogenesis of psychiatric
disorders. Furthermore, we discuss the basis for selecting Reelin and molecules
in its downstream signaling pathway as potential therapeutic targets for psychiatric
illnesses.
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INTRODUCTION
Falconer (1951) first described the mutant reeler mouse, which is characterized by reeling gait
caused by dysregulation of motor coordination and ataxia. More than four decades later, the
gene responsible for the reeler phenotype was identified and the protein encoded by the gene was
named Reelin (Bar et al., 1995; D’Arcangelo et al., 1995; Hirotsune et al., 1995; Ogawa et al., 1995).
Until date, much work has been carried out towards understanding the functions of Reelin during
cortical development, because the Reelin-deficient mutant mouse, reeler, shows largely inverted
cortical layers (Caviness and Sidman, 1973; Tissir and Goffinet, 2003; Honda et al., 2011; Sekine
et al., 2014).
Reelin is a glycoprotein secreted mainly from the Cajal-Retzius cells in the developing cerebral
cortex and hippocampus, and acts as a key regulator of various aspects of laminar formation,
including neuronal migration, cell aggregation and dendrite formation (Nakajima et al., 1997;
Kubo et al., 2010; Franco et al., 2011; Jossin and Cooper, 2011; Sekine et al., 2014; Kohno et al.,
2015). Many downstream molecules and several pathways involved in Reelin signaling during
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 October 2016 | Volume 10 | Article 229
Ishii et al. Reelin and Neuropsychiatric Disorders
development have been elucidated from animal studies (Howell
et al., 1997; Hiesberger et al., 1999; Ballif et al., 2004; Honda et al.,
2011; Jossin and Cooper, 2011; Sekine et al., 2012; Figure 1).
In the postnatal period, the distribution and expression
patterns of Reelin are dramatically changed as compared to
those during the embryonic period (Alcántara et al., 1998). This
suggests that the roles of Reelin in the postnatal brain might also
be changed. Intriguingly, a number of lines of evidence indicate
that Reelin signaling modulates synaptic function in the adult
brain (Herz and Chen, 2006; Figure 2).
In humans, genetic studies have reported that the RELN
locus is associated with neuropsychiatric disorders, such as
Schizophrenia (SZ), bipolar disorder (BP), autism spectrum
disorder (ASD) and Alzheimer’s disease (AD; Ovadia and
Shifman, 2011; Wang et al., 2014; Bufill et al., 2015; Li
et al., 2015). Indeed, homozygous (rl/rl) and heterozygous
reeler (rl/-) mice haploinsufficient for Reelin show cognitive
and behavioral abnormalities (Tueting et al., 1999; Qiu et al.,
2006a), supporting the notion that RELN haploinsufficiency may
lead to higher brain dysfunctions relevant to neuropsychiatric
disorders in humans. A number of studies have revealed that
Reelin also plays a pivotal role in regulating synaptic functions,
including N-methyl-d-aspartate (NMDA) receptor signaling
(Beffert et al., 2005; Qiu et al., 2006b), and these findings
may give a clue to uncover the impairments in the Reelin
signaling pathway underlying the development of psychiatric
disorders.
In this article, we first provide an overview of the current
progress in Reelin research at the molecular, cellular and
tissue levels. Second, we review human genetic studies of
FIGURE 1 | Reelin signaling pathway in the developing cortex. The Reelin protein binds to very-low-density lipoprotein receptor (VLDLR) and apolipoprotein E
receptor 2 (ApoER2). Then, Dab1 is phosphorylated by the Src-family tyrosine kinases (SFKs). Phosphorylated Dab1 recruits downstream molecules such as
Crk/CrkL, phosphatidylinositol 3-kinase (PI3K) and Nckβ. CrkL binds to C3G, an effector protein. C3G promotes the formation of Rap1-GTP, which activates cell
adhesion molecules, including α5β1 integrin and N-cadherin. There are also Dab1-PI3K-mTOR, Dab1-PI3K-cofilin and Dab1-Nckβ pathways, which regulate the
actin cytoskeleton relevant to dendrite formation and neuronal migration in the developing cortex.
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FIGURE 2 | Reelin signaling pathway in the adult brain, which regulates
synaptic function. Reelin binds to ApoER2 and activates SFKs, which
phosphorylate a tyrosine of the NR2 subunit of the N-methyl-D-aspartate
(NMDA) receptor, resulting in the potentiation of NMDA receptor-mediated
Ca2+ influx. ApoER2 binds to PSD-95, a scaffolding protein in the post
synapse. ApoER2 is proteolytically cleaved by γ-secretase activity, which is
activated by NMDA receptor signaling. Then, the intracellular domain of
ApoER2 (ApoER2-ICD) is released from the cell membrane and translocates
into the nucleus and activates transcriptional factors, including MEF2 and
CREB. In the presynapse, the Reelin-ApoER2-PI3K pathway promotes Ca2+
influx, which leads to the selective mobilization of VAMP7-enriched synaptic
vesicles, promoting neurotransmitter release.
neuropsychiatric disorders associated with mutations in the
RELN gene locus. Then, we focus on how Reelin dysfunction
leads to the behavioral abnormalities relevant to neuropsychiatric
diseases in mouse models. Finally, we discuss the basis for
selecting Reelin and molecules in its downstream signaling
pathway as potential therapeutic targets for neuropsychiatric
disorders.
REELIN HAS AN ESSENTIAL ROLE IN
CORTICAL DEVELOPMENT
In mammals, cortical expansion is thought to contribute
to the acquisition of higher brain functions during the
course of evolution (Molnar et al., 2006). The neocortex is
composed of a well-organized six-layer structure, including
excitatory and inhibitory neurons (Rakic, 2009). The excitatory
neurons, born directly or indirectly from the radial glia
(Tabata et al., 2009; Sekine et al., 2013), which are neural
progenitor cells located in the ventricular zone, migrate
radially towards the brain surface, and eventually reach their
final destinations (Rakic, 1972). Since the late-born neurons
migrate past their predecessors, the earlier-born neurons are
placed at a deeper position and the later-born neurons at a
more superficial position in the cortical plate (CP; Caviness,
1982; Takahashi et al., 1999). This pattern of cell alignment
is called a birth-date-dependent ‘‘inside-out’’ pattern. By
contrast, inhibitory interneurons are born in the ganglionic
eminences (GEs) in the ventral telencephalon and preoptic
area in the rostral diencephalon that are located far from
their final destination, and migrate tangentially for a long
distance towards the dorsal pallium (Anderson et al., 1997;
Tamamaki et al., 1997; Yozu et al., 2005; Kanatani et al.,
2008, 2015; Gelman et al., 2009, 2011; Marin et al., 2010).
Correct neuronal migration and laminar formation are essential
for the establishment of proper brain functions. Indeed,
disruption of the cortical architecture has been observed in
various neuropsychiatric disorders (Arnold, 2000; Wegiel et al.,
2010).
Reelin is a glycoprotein that is mainly secreted from
the Cajal-Retzius cells located in the marginal zone (MZ),
and a subpopulation of GABAergic interneurons (Rice and
Curran, 2001). Reelin-deficient mice, reeler, show largely
inverted cortical layers, which strongly supports the notion that
Reelin is a key regulator of cortical development. A recent
study showed that cortical laminar formation in reeler brains
exhibit a more complex pattern than previously thought. Boyle
et al. (2011) reported that the layer formation is severely
disorganized in the reeler cortex, with layer II/III neurons
located in the middle of the cortex and cells from other
layers (layer IV, V and VI) split between the deep and
superficial layers in a mirror image fashion. The secreted Reelin
protein binds to its receptors, apolipoprotein E receptor 2
(ApoER2) and very-low-density lipoprotein receptor (VLDLR),
which are mainly expressed on the cell membrane of cortical
neurons (Trommsdorff et al., 1999; Hirota et al., 2015).
Then, disabled homolog 1 (Dab1), an intracellular adaptor
protein, is phosphorylated via Fyn and Src, the Src-family
tyrosine kinases (SFKs; Hiesberger et al., 1999; Howell et al.,
1999). Phosphorylated Dab1 recruits and binds with several
downstream molecules, including Crk, phosphatidylinositol 3-
kinase (PI3K), and Nckβ (Beffert et al., 2002; Pramatarova
et al., 2003; Park and Curran, 2008). The Crk family
proteins (Crk and CrkL) are adaptor proteins that bind
to phosphorylated Dab1 and recruit their effector proteins
(Chen et al., 2004). Park and Curran (2008) reported that
conditional double-knockout mice of Crk and CrkL showed
the major anatomic features of reeler, including disruption
of layer formation in the cerebral cortex and hippocampus,
absence of preplate splitting, impaired dendrite formation,
and cerebellar hypofoliation. The brains of mice deficient
in C3G, an effector protein of CrkL, also show impaired
preplate splitting (Voss et al., 2008). These findings indicate
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the Reelin-Dab1-Crk/CrkL pathway plays a critical role in
controlling layer formation in the cortex, including preplate
splitting. Sekine et al. (2012) recently reported that Reelin
activates integrin α5β1 through an intracellular Dab1-Crk/CrkL-
C3G-Rap1 pathway. Furthermore, they showed that activated
integrin α5β1 controls the terminal translocation, a final mode
of neuronal movement beneath the MZ (Nadarajah et al.,
2001; Sekine et al., 2011, 2012). Other groups reported that
Reelin signaling regulates the function of another cell adhesion
molecule, N-cadherin. Franco et al. (2011) reported that Dab1
acts on the migratory neurons to stabilize their leading processes
in a Rap1-dependent manner. They showed that Rap1 regulates
the function of N-cadherin and finally controls the somal
translocation (Franco et al., 2011). The same group also reported
that N-cadherin activated through the Reelin-Rap1 pathway
enhances heterotypic cell-cell contact between the Cajar-Retzius
cells and migratory neurons (Gil-Sanz et al., 2013). Jossin
and Cooper (2011) demonstrated that the Rap1-N-cadherin
pathway also regulates the transition of migratory neurons from
multipolar cells to bipolar cells beneath the CP; this mode
change is crucial for the migratory neurons to enter the CP
(Figure 1).
Reelin signaling plays a role in the processes of dendrite
development (Olson et al., 2006; Jossin and Goffinet, 2007).
Olson et al. (2006) found that Dab1-suppressed migrating
neurons showed simplified leading processes that were less
likely to attach to the MZ and exhibited abnormal cell
positioning. Jossin and Goffinet (2007) reported that Reelin
promoted dendritogenesis through activation of mammalian
target of rapamycin (mTOR) and S6 kinase 1 (S6K1) in a
Dab1-, PI3K- and Akt-dependent manner. In regard to axon
formation, by ablation of Cajal-Retzius cells in a slice and
analysis of reeler mice, Del Rio et al. (1997) demonstrated
abnormalities in the development of axon fibers from the
entorhinal cortex to the hippocampus. However, using reeler
cortical explants, Jossin and Goffinet (2001) found that Reelin
itself did not exhibit any significant attraction or repulsion to
cortical axons.
In the adult brain, the main source of Reelin is no longer
the Cajal-Retzius cells, but a subpopulation of GABAergic
interneurons, a change that is also associated with a change in the
distribution pattern of Reelin (Alcántara et al., 1998; Pesold et al.,
1998). These findings suggest that the roles of Reelin in the adult
brain may also be different from those in the developing brain.
We shall review and discuss the functions of Reelin in the adult
brain in ‘‘Reelin Regulation of Brain Function and Behavior’’
Section.
GENETIC STUDY OF RELN IN
NEUROPSYCHIATRIC DISORDERS
In humans, the mutations of the RELN have been shown
to be associated with autosomal recessive lissencephaly
with cerebellar hypoplasia (Hong et al., 2000). The brain
phenotypes in these patients are similar to those found
in the reeler mice, including abnormal laminar formation
and cerebellar hypoplasia. In addition to this severe brain
malformation, mutations in the RELN locus are also
associated with neuropsychiatric disorders, with no apparent
abnormalities in the brain structure. In this section, we
provide an overview of the recent genetic studies carried out
to examine the association of RELN with neuropsychiatric
disorders.
Schizophrenia
SZ is a devastating psychiatric disease that affects approximately
1% of the population and is characterized by hallucinations,
delusions and cognitive disturbances. The first clinical features
of SZ typically emerge between early childhood and adolescence,
with many patients experiencing chronic SZ symptoms (Sawa
and Snyder, 2002). The clinical symptoms are based on brain
dysfunctions attributed to genetic and environmental factors
(Insel, 2010). As SZ shows high heritability, the risk genes
with the greatest impact on the predisposition to SZ have been
pursued by many researchers (Schizophrenia Working Group
of the Psychiatric Genomics Consortium, 2014). As for the
RELN gene, Li et al. (2013) conducted a case-control association
study and identified six single-nucleotide polymorphisms (SNPs;
rs2237628, rs362626, rs362814, rs362813, rs362731, rs362726)
which are located in the intron 29 of the RELN gene that
were significantly associated with the risk of SZ in the Chinese
population. Several groups have reported that the existence
of a gender-specific (women) association between SNPs in
RELN and SZ (Shifman et al., 2008; Kuang et al., 2011; Li
et al., 2011). Li et al. (2011) also reported the association
of another SNP (rs12705169) in the RELN locus with SZ.
Although rs12705169 is located in the intron of RELN and does
not lead to any change of the protein structure or function,
it may be involved in alternative RNA splicing and miRNA
generation. When they divided the subjects by gender, they
found that this SNP was positively associated with SZ only
in women. Similarly, Kuang et al. (2011) demonstrated an
association of rs362719 of RELN, which is located in the
exon 42 and contributes to the EGF-like domain of the fifth
Reelin repeat, with susceptibility to SZ in their female, but
not male, participants. Shifman et al. (2008) performed a
genome-wide association study (GWAS) for SZ in Ashkenazi
Jews and showed that rs7341475, a SNP in the intron four of
the RELN, was associated with SZ only in women. However,
the association of this SNP (rs7341475) with SZ was not
replicated in any other study in the Chinese population (Liu
et al., 2011). Subsequently, Ben-David and Shifman (2010)
performed a meta-analysis of four GWAS studies to assess the
association of rs7341475 with SZ, and suggested this locus might
have a small effect on the SZ risk. Therefore, the association
of rs7341475 with SZ may remain inconclusive. Wedenoja
et al. (2008) replicated the previous linkage of SZ on 7q22
in an independent subject. They also studied four candidate
genes, including RELN. Although the selected candidate genes
showed no association to the clinical diagnosis of SZ, the
quantifiable trait component analysis revealed that allelic variants
of RELN contributed to the endophenotypes of SZ, including
working memory and executive function (Wedenoja et al.,
2008).
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Other Neuropsychiatric Disorders and
Neurological Diseases
ASD is characterized by impairments of social interaction and
communication, as well as repetitive behaviors and restricted
interests (Maenner et al., 2014). Twin and family studies have
revealed the important role of genetic factors in ASD, with
a heritability value of as high as 90% (Freitag et al., 2007).
Although many studies have been conducted to explore the
genetic association between RELN and ASD, the results have
been inconclusive. Persico et al. (2001) was the first to report
that polymorphic GGC repeats located in the 5′ untranslated
region (5′ UTR) of the RELN were associated with autistic
disorder, finding that was subsequently replicated in three studies
(Zhang et al., 2002; Skaar et al., 2005; Dutta et al., 2007).
However, other groups have failed to show an association
between the triplet repeats in the 5′ UTR of the RELN and
autism (Krebs et al., 2002; Bonora et al., 2003; Devlin et al.,
2004; Li et al., 2004). In the family-based association analyses
carried out by Serajee et al. (2006), the most significant results
were the apparent association of autism, in a broad diagnosis
of the disease, with rs736707 in intron 59 and rs362691 in
exon 22 of the RELN. Li et al. (2008) also showed a significant
genetic association between rs736707 in intron 59 and ASD in
a Han Chinese population. On the other hand, other groups
have failed to detect these associations (Dutta et al., 2008;
He et al., 2011). Dutta et al. (2008) carried out case-control
and family-based association studies for six SNPs (rs727531,
rs2072403, rs2072402, rs362691, rs362719, rs736707), and found
that these SNPs of RELN were unlikely to be associated with
ASD. Recently, a Chinese group conducted a meta-analysis for
case-control and transmission disequilibrium test (TDT) studies
published from 2001 to 2013 and concluded that rs362691
might contribute significantly to the risk of ASD (Wang et al.,
2014).
There are only a few reports that suggested the existence of an
association between the RELN and BP (Goes et al., 2010; Ovadia
and Shifman, 2011). Goes et al. (2010) found that the rs362719
of RELN was associated with susceptibility to BP, particularly in
females.
Several groups have also reported an association between
AD and the RELN gene (Seripa et al., 2008; Antoniades
et al., 2011; Kramer et al., 2011; Bufill et al., 2015; Fehér
et al., 2015). AD is a neurodegenerative disease characterized
by the formation of neurofibrillary tangles and beta-amyloid
plaques in the brain, and patients clinically manifest progressive
impairments of memory and cognition (Scheltens et al., 2016).
Several SNPs in the RELN gene have been reported to be
associated with the risk of AD. Seripa et al. (2008) showed
an association between a triplet tandem repeat in the 5′UTR
and rs607755 with AD, particularly in females. Another group
also showed significant association between rs607755 and the
risk of AD (Fehér et al., 2015). However, their results were
inconsistent with the conclusion by Seripa et al. (2008) that
rs607755 was significantly associated with AD only in males
(Fehér et al., 2015). Antoniades et al. (2011) reported that an
SNP in exon 22 of RELN (rs362691) was significantly associated
with the risk of AD in a Greek population. Bufill et al. (2015)
reported that SNPs in the RELN gene (rs528528 and rs2299356)
and two genes (PLK2 and CAMK2A) related to the Reelin
signaling pathway were associated with AD and mild cognitive
impairment (MCI).
REELIN REGULATION OF BRAIN
FUNCTION AND BEHAVIOR
Expression Level of Reelin and
Vulnerability to Neuropsychiatric Disorders
Many studies have provided evidence for altered Reelin
expression in rodents with cognitive dysfunction, which may
relate to neuropsychiatric diseases. Heterozygous reeler mice
(HRM), in which the amount of Reelin protein is approximately
50% as compared to that in the wild type mice, exhibit
behavioral abnormalities (Costa et al., 2002). Thus, HRM has
been of interest as an animal model of psychiatric diseases.
In spite of the initial inconsistent findings on the occurrence
of behavioral deficits in HRM (Salinger et al., 2003; Podhorna
and Didriksen, 2004), many groups have reported behavioral
traits associated with Reln haploinsufficiency in HRM (Tueting
et al., 1999; Qiu et al., 2006a; Barr et al., 2007, 2008; Teixeira
et al., 2011; Kutiyanawalla et al., 2012; Iafrati et al., 2014).
Several groups have also reported defect in the prepulse
inhibition (PPI), an impairment of sensory motor gating that
is associated with SZ, in HRM (Tueting et al., 1999; Barr
et al., 2008; Teixeira et al., 2011; Kutiyanawalla et al., 2012).
Iafrati et al. (2014) showed that Reelin deficiency in HRM
caused defects in the juvenile morphofunctional properties
of excitatory synapses in the prefrontal cortex (PFC) and
behavioral dysfunction in prefrontal circuits. Furthermore, Barr
et al. (2007) showed that the Reelin receptors VLDLR and
ApoER2 regulated sensory motor gating. They demonstrated
that acoustic PPI was intact in both Vldlr- and Apoer2-mutant
mice. However, Vldlr-homozygous knockouts mice exhibited
deficits in crossmodal PPI, while Apoer2-heterozygous and
homozygous knockouts mice exhibited increased crossmodal
PPI (Barr et al., 2007). Qiu et al. (2006a) demonstrated
that HRM exhibited hippocampus-dependent learning deficit
underlying the impairment of hippocampal plasticity. There
are several interesting studies to show that mouse behavioral
alterations are manifested as a consequence of gene-environment
interaction, similar to many psychiatric disorders in humans
(Laviola et al., 2009; Romano et al., 2014; Howell and
Pillai, 2016). There have also been a number of reports
indicating that in humans, the amount of Reelin protein in
the brain, plasma and cerebrospinal fluid (CSF) are associated
with neuropsychiatric conditions. Almost all studies have
shown that the reduced amount of Reelin in the brain and
blood are associated with a high risk of development of
neuropsychiatric disorders (Guidotti et al., 2000; Fatemi et al.,
2005; Eastwood and Harrison, 2006). Interestingly, however,
increased expression levels of Reelin in the CSF (Sáez-Valero
et al., 2003) and frontal cortex (Botella-López et al., 2006)
were found in case of AD. Accumulation of Reelin has also
been reported in amyloid-like plaques, with a decline in
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Reelin-positive neurons, which might represent a risk factor
for AD (Knuesel et al., 2009). Reelin protein itself is thought
to be protective against AD-like neuropathology, since the
reduced Reelin expression in a transgenic AD background
markedly elevated amyloid-β plaque formation (Kocherhans
et al., 2010).
The Expression Level of Reelin is
Regulated by Multiple Mechanisms
In addition to genetic mutations/polymorphisms, various
mechanisms may lead to aberrant expression of Reelin.
In the postnatal brain, the main source of Reelin is
shifted from Cajal-Retzius cells to a subpopulation of
GABAergic interneurons (Alcántara et al., 1998; Pesold
et al., 1998). Using in situ hybridization analysis combined
with immunohistochemistry, Pesold et al. (1998) showed
that Reelin is preferentially expressed in GABAergic
interneurons in the adult rat cortex and hippocampus.
Furthermore, they found Reelin immunoreactivity not only
in neurons, but also in the extracellular space, suggesting
that the GABAergic interneurons secrete Reelin into the
extracellular matrix (Pesold et al., 1998). However, how
Reelin is secreted by these specialized interneurons in the
postnatal brain remains an unresolved question, although a
constitutive mechanism dependent on a specific sequence of
positively charged amino acids in the Reelin carboxy terminus
domain has been reported (Rodriguez et al., 2000). Thus, in
mature brains, the amount of secreted Reelin protein may
depend on the number and distribution of Reelin-positive
interneurons.
Several studies have shown the involvement of epigenetic
mechanisms in the transcriptional regulation of RELN
(Abdolmaleky et al., 2005; Grayson et al., 2005). Grayson
et al. (2005) analyzed the pattern of methylation within the CpG
island of the RELN promoter in human SZ brains obtained
from a brain bank. They showed hypermethylation of the
promoter region of RELN in the SZ brains (Grayson et al., 2005).
Abdolmaleky et al. (2005) also demonstrated hypermethylation
of a CpG island containing CRE and an SP1-binding site in
the promoter region of RELN in post-mortem examination
of the brains of SZ patients. However, Tochigi et al. (2008)
reanalyzed this RELN promoter region by using the same
brain samples as in the previous study, and showed that the
extent of methylation in this promoter region did not differ
significantly between the SZ patients and controls. Furthermore,
Mill et al. (2008) prepared a microarray-based comprehensive
epigenomic scan and found epigenetic changes in the loci
associated with glutamatergic and GABAergic neurotransmitter
pathways. However, they did not detect any association
between hypermethylation in the promoter region of RELN
and major psychosis. Recently, a systematic review of DNA
methylation in SZ and BP has been reported (Teroganova et al.,
2016). Although a number of differentially methylated genes
were detected, including RELN, diverse methodologies used
across studies hampered the reliability of the meta-analysis
(Teroganova et al., 2016). Thus, in regard to the epigenetic
regulation of RELN expression, further investigation is needed
to confirm the association of hypermethylation in the RELN
promoter region with the predisposition to major mental
illnesses.
Perturbation of transcriptional regulation could affect the
Reelin protein distribution as well as expression levels.
Baek et al. (2015) reported that RELN transcription was
derepressed in ectopic cortical regions, mediated by activation
of the transcription factor FOXG1 in human focal cortical
malformations. They found that misexpression of Reelin in
the progenitor cells caused non-cell autonomous neuronal
migration defects, resulting in focal cortical malformations.
These results may, at least to some extent, resemble the effects
of ectopic Reelin overexpression in the mouse brain (Kubo et al.,
2010).
Reelin Signaling is Involved in Synaptic
Functions and Behavior
During cortical development, the main source of Reelin is
the Cajal-Retzius cells located in the MZ. Subsequently, these
cells gradually disappeared, and the main source of Reelin
finally shifts to a subtype of GABAergic interneurons (Miyoshi
et al., 2010). Thus, during this period, the expression pattern
of Reelin changes dynamically. This suggests that the role of
Reelin in the postnatal brain also changes dramatically. Indeed,
in adulthood, there is much evidence to indicate that Reelin
modulates NMDA receptor-mediated synaptic functions (Beffert
et al., 2005; Iafrati et al., 2014; Figure 2). Dysfunction of
NMDA receptor signaling plays a key role in the pathogenesis
of major neuropsychiatric disorders, including SZ and AD
(Zhou and Sheng, 2013). Recently, it has been reported that
hundreds of genetic loci were associated with SZ in a large-
scale GWAS (Schizophrenia Working Group of the Psychiatric
Genomics Consortium, 2014). In this analysis, the glutamatergic
neurotransmission-related genes including GRIN2A, a NMDA
receptor subunit, were highly associated with SZ. NMDA
dysfunction has also been reported to be related to cognitive
impairment in AD. In addition to the widely used drug,
cholinesterase inhibitors, for AD, a new drug that modulates
glutamate signaling has also become available recently for
AD (Scarpini et al., 2003). Also, it has been shown that
Reelin acts on NMDA receptor signaling via ApoER2, a
Reelin receptor (Beffert et al., 2005; Chen et al., 2005; Herz
and Chen, 2006). Beffert et al. (2005) demonstrated that an
alternative splicing variant of ApoER2 modulated the NMDA
receptor activity through Reelin signaling. They found that
alternatively spliced exon 19, which encodes amino acids in the
intracellular domain of ApoER2 (ApoER2-ICD), is necessary
for the stimulation of tyrosine phosphorylation of the NMDA
receptor subunit NR2 in hippocampal slices in response to
Reelin. Furthermore, they confirmed that the mice expressing
a mutant ApoER2 lacking exon 19 showed severe cognitive
disturbances related to the NMDA receptor function (Beffert
et al., 2005). Interestingly, birds do not have exon 19 (Brandes
et al., 1997), suggesting that adding this new exon may
partly contribute to the acquisition of higher brain functions
in mammals. Chen et al. (2010) further showed that the
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Reelin-ApoER2-NMDA receptor pathway is involved in the
pathophysiology of AD. They demonstrated that ApoE4, which
is associated with an earlier average age at onset of dementia,
depletes ApoER2 from the neuronal surface after ligand-induced
endocytosis by Reelin, which impairs synaptic plasticity and
NMDA phosphorylation induced by Reelin (Chen et al., 2010).
Moreover, Lane-Donovan et al. (2015) demonstrated that Reelin
signaling protects against the Aβ toxicity that induces synaptic
dysfunction in the early stages of aging. Using Reelin conditional
knockout mice, they found that the loss of Reelin rendered
excitatory synapses susceptible to functional suppression by
Aβ, which resulted in impaired learning and memory. Iafrati
et al. (2014) demonstrated that in vivo injection with ketamine,
an NMDA receptor antagonist, or Ro25-6981, an inhibitor of
GluN2B-NMDA receptors, in the juvenile period rescued the
behavioral abnormalities, reduced the dendritic spine density,
and anomalous long-term potentiation (LTP) in the PFC of
HRM. Their results suggest Reelin is essential for proper
functional and behavioral development of juvenile prefrontal
circuits through modulating the NMDAR-mediated signaling
pathway.
Reelin signaling is also involved in the presynaptic functions
(Figure 2). Reelin acts presynaptically in mature neurons
to rapidly enhance neurotransmitter release. This role of
Reelin depends on the function of VAMP7, a vesicular
SNARE protein (Bal et al., 2013). Telese et al. (2015)
reported interesting findings; they reported that the Reelin
pathway controls learning and memory through activation
of the transcriptional factors. Proteolytic cleavage of ApoER2
is a crucial component of the synapse-to-nuclear signaling
triggered by Reelin. When Reelin binds to its receptor
ApoER2, nuclear translocation of the ApoER2-ICD is triggered.
Then, ApoER2-ICD binds to the transcriptional factors MEF2
and CREB, and as a result, expressions of some genes
involved in synaptic plasticity are activated (Telese et al.,
2015).
Observations in animal studies using reeler and Reelin
receptor mutant mice support the notion that Reelin-synapse
dysfunction leads to cognitive dysfunction and neuropsychiatric
symptoms (Weeber et al., 2002; Qiu et al., 2006a,b; Pujadas
et al., 2010; Trotter et al., 2013). Several groups have reported
that Reelin plays an important role in synaptic plasticity,
mainly dependent on the NMDA receptor dysfunction in the
hippocampal region (Weeber et al., 2002; Qiu et al., 2006b;
Pujadas et al., 2010). Weeber et al. (2002) reported that Reelin
signaling is crucial for memory formation and synaptic plasticity
in the hippocampal CA1 region. They demonstrated using
hippocampal slices, that mice with KO of each of the Reelin
receptors, VLDLR and ApoER2, exhibited defects in LTP. They
further showed that treatment of the hippocampal slices obtained
from wild-type mice with Reelin significantly enhanced the LTP
in the CA1 region, which was abolished in mice deficient in
either of the receptors. Qiu et al. (2006b) replicated Weeber’s
findings by using HRM. They also observed defect of LTP in
the CA1 region by electrophysiological analysis. In addition,
according to a report by Pujadas et al. (2010), overexpression
of Reelin enhanced the synaptic function in the hippocampus.
They generated transgenic mice that overexpressed Reelin under
the control of the CaMKIIα promoter. The mice showing
Reelin overexpression exhibited increased spine hypertrophy
and LTP in the hippocampus (Pujadas et al., 2010). Trotter
et al. (2013) generated Dab1-conditional knockout mice and
examined the spine morphology and synaptic functions. They
conditionally deleted Dab1 protein from the excitatory neurons
of the adult forebrain using Dab1flox/flox; CaMKII-Cre mice.
This Cre driver line exhibits Cre expression in the forebrain,
starting at approximately P19. They showed that loss of Dab1
led to a reduction of the spine size, suppression of Akt
and ERK signaling, loss of hippocampal LTP, and deficits in
hippocampus-dependent learning and memory. These results
obtained using transgenic mice are consistent with the previous
results obtained using reeler mice (Pujadas et al., 2010;
Trotter et al., 2013). Furthermore, recently, Imai et al. (2016)
generated dorsal forebrain-specific Dab1 conditional knockout
mice (Dab1flox/flox; Emx1-Cre mice), in which Cre is expressed
specifically in the dorsal forebrain from the beginning of
corticogenesis, and performed behavioral tests. These Dab1-
conditional knockout mice showed normal motor functions,
but exhibited hyperactivity, decreased anxiety-like behavior,
and deficits in spatial reference and working memory (Imai
et al., 2016). In these mice, in addition to the deficient Reelin-
Dab1 signaling, the disorganized laminar structure in the
cerebral cortex might also have contributed to the observed
behavioral abnormalities. The best way to understand Reelin
function in adulthood is to analyze conditional Reelin gene
(Reln) knockout mice. Lane-Donovan et al. (2015) generated
inducible conditional Reln knockout mice and analyzed them.
After Reelin inactivation at 2 months of age, they found
that while the mice had no apparent abnormalities of the
cortical structure, they did exhibit mild behavioral changes
and electrophysiological phenotype. Importantly, the behavioral
phenotypes in the conditional Reln knockout mice may be
somewhat different from those observed in Reln-deficienct
(homozygous and heterozygous reeler) mice, whichmay be based
on the degree of structural abnormalities. In themature brain, the
structure would not be seriously affected by Reelin deficiency.
By contrast, Reelin deficiency during the developmental and
early postnatal stages would severely affect the brain structure,
which may be related to the development of some types
of young-onset mental disorders. Further investigations in
conditional Reln knockout mice are needed to clarify this
issue.
In humans, dysfunction of the PFC, which plays crucial roles
in cognitive functions, has been implicated in many psychiatric
disorders (Weinberger et al., 1988). Analogous to the human
PFC, the medial PFC (mPFC) is involved in various cognitive
functions and social behaviors in rodents (Ishii et al., 2015a).
Brosda et al. (2011) demonstrated that Reelin knockdown in
the mPFC resulted in behavioral alterations in young adult
rats, including disruption of sensorimotor gaiting and deficits
in spatial working memory as well as object recognition. Sui
et al. (2012) also reported that the expression level of Reelin was
related to the regulation of LTP in the rat mPFC. They found
that epigenetic regulation ofRelnwas involved in the induction of
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LTP in themPFC, which resulted in behavioral alterations. Iafrati
et al. (2014) also reported that HRM showed reduced dendritic
spine density and abnormal LTP in the PFC. Interestingly, Ishii
et al. (2015b) demonstrated dominant expression of VLDLR in
both excitatory pyramidal neurons and GABAergic inhibitory
interneurons, except for the migrating interneurons in the rostral
migratory stream in the postnatal mPFC. As compared to the
findings in the hippocampus, there is not much evidence to
support the importance of Reelin signaling in the synaptic
functions in the mPFC. Further investigations are needed to
elucidate the role of Reelin in the functions of the mPFC relevant
to mental illnesses.
REELIN AND ITS DOWNSTREAM
SIGNALING MOLECULES AS A TARGET
OF THERAPEUTIC INTERVENTION
The findings described in the above sections suggest that Reelin
pathways could be potentially useful as targets of therapeutic
interventions for neuropsychiatric disorders. Indeed, several
groups have directly assessed this possibility by examining the
effects of administration of Reelin protein into the mouse brain
(Rogers et al., 2011, 2013; Hethorn et al., 2015; Ishii et al.,
2015b). Ishii et al. (2015b) demonstrated that Reelin exerted
a preventive effect on phencyclidine (PCP)-induced behavioral
deficits. They injected a conditioned medium containing Reelin
protein into the mouse cerebral ventricles before administering
PCP, and assessed the behavior of the animals. The group
of mice that had received prior administration of Reelin
showed normal cognitive and sensory-motor gating, indicating
that the PCP-induced brain dysfunction was prevented by
the Reelin injection. This study is based on their previous
findings that prior transplantation of GABAergic neuronal
progenitors into the mPFC of mice prevented the behavioral
deficits induced by PCP and that the transplanted progenitors
preferentially differentiated into Reelin/somatostatin-double
positive GABAergic neurons specifically in the mPFC (Tanaka
et al., 2011). Another group demonstrated that in vivo injection
of Reelin into the mouse cerebral ventricle affected the synaptic
functions and cognitive functions in wild-type mice and
HRM (Rogers et al., 2011, 2013). The same group further
showed that Reelin administration ameliorated both the synaptic
plasticity and the cognitive behavioral deficits in a mouse
model of Angelman syndrome, which is characterized by mental
retardation, absence of speech, seizures and motor dysfunction
(Hethorn et al., 2015).
Although we cannot directly apply this strategy of directly
injecting Reelin into the human brain, modulating the activities
of the signaling molecules downstream of Reelin could be a
potential therapeutic approach. Reelin has been shown to activate
PI3K and Akt (protein kinase B), to inhibit glycogen synthase
kinase 3β (GSK3 β; Beffert et al., 2002) and activate the mTOR-
S6K1 pathway (Jossin and Goffinet, 2007). Among them, GSK3
is already known as a target for mood stabilizers (De Sarno et al.,
2002) and antipsychotics (Emamian et al., 2004; Li et al., 2007). In
addition, animal models with disrupted mTOR signaling exhibit
cognitive and behavioral deficits mimicking neuropsychiatric
symptoms (Gururajan and van den Buuse, 2014). On the other
hand, rapamycin, a well-established mTORC1 inhibitor, has
been demonstrated to rescue cognitive impairments in several
neurodevelopmental models of neuropsychiatric disorders, such
as those of serotonin receptor (5-HT6) activation, neonatal PCP
treatment, and post-weaning social isolation (Meffre et al., 2012),
indicating overstimulation of mTOR signaling in these models.
Surprisingly, rapamycin treatment also rescues lamination
defects in tuberous sclerosis complex (TSC) 2-deficient mice, in
which loss of TSC2 leads to activation of mTOR signaling and
aberrant regulation of Reelin-Dab1 signaling (Moon et al., 2015).
This inconsistency in the mTOR activities between different
models might be explained by the varied activities of mTOR
signaling as well as Reelin signaling among different brain
regions and/or neuronal populations. Since such variation of
Reelin (and its downstream) signaling activities could underlie
the complex behavioral phenotypes of human neuropsychiatric
disorders, further studies are required to distinguish clinical
phenotypes and/or subpopulations that reflect disrupted Reelin
signaling.
CONCLUSION
In the developing cortex, Reelin is a key regulator of neuronal
migration and laminar formation, which are essential for
achieving higher brain functions in mammals. Intriguingly,
however, the expression pattern of Reelin and its functions
are dramatically different in the postnatal brain as compared
to the embryonic brain. Indeed, Reelin modulates synaptic
functions, which may also be based on the structural changes
of the dendrites and spines in the postnatal period, which are
closely related to cognitive behaviors and predisposition to
neuropsychiatric symptoms. Although genetic studies have
lent support to the notion of an association between the
RELN gene and neuropsychiatric disorders, recent large-scale
genome-wide analyses have revealed that the contribution
of RELN mutations/polymorphisms to the development of
neuropsychiatric disorders is not much higher than previously
thought. However, many studies have indicated multiple
mechanisms underlying the regulation of Reelin production, e.g.,
epigenetic regulation, cleavage events, and subtype specification
of GABAergic interneurons. Perturbation of these regulatory
mechanisms can also lead to brain dysfunction. The findings
of animal experiments suggest that Reelin and its downstream
signaling are closely related to the synaptic functions that
underlie the mouse behaviors relevant to neuropsychiatric
disorders. Therefore, the Reelin pathway is a potential
therapeutic intervention target for neuropsychiatric disorders.
Further investigations are needed to clarify how Reelin signaling
regulates the higher brain functions and how it is involved in the
development of neuropsychiatric disorders.
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